Local application of rapamycin inhibits vein graft restenosis in rabbits

Transplantation Proceedings

Volumn 43, Issue 5, 2011, Pages 2017-2021

  Chen, H L ^a   Liu, K ^a   Meng, X Y ^a   Wen, X D ^a   You, Q S ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; POLOXAMER; RAPAMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; EXTERNAL JUGULAR VEIN; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTENOSIS; STAINING; VEIN GRAFT;

ADMINISTRATION, TOPICAL; ANIMALS; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; MALE; RABBITS; SIROLIMUS; VEINS;

EID: 79959427938     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.12.063     Document Type: Article

References (17)

1. C.M. Grondin, L. Campeau, and J.C. Thornton Coronary artery bypass grafting with saphenous vein Circulation 79 1989 124
2. S. Goldman, K. Zadina, and T. Moritz Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs cooperative study J Am Coll Cardiol 44 2004 2149
3. M.G. Bourassa Fate of venous grafts: the past, the present, and the future J Am Coll Cardiol 5 1991 1081
4. G.M. Fitzgibbon, H.P. Kafka, and A.J. Leach Coronary bypass graft fate and patient outcome: angiographic follow-up of 5065 grafts related to survival and reoperation in 1388 patients during 25 years J Am Coll Cardiol 28 1996 616
5. S.E. Francis, S. Hunter, and C.M. Holt Release of platelet derived growth factor activity from pig venous arterial grafts Thorac Cardiovasc Surg 108 1994 540
6. M. Kalra, and V.M. Miller Early remodeling of adventitial and medial cells occur simultaneously with changes in graft diameter and blood flow J Vasc Res 37 2000 567
7. S.O. Marx, T. Jayarman, and L.O. Go Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells Circ Res 76 1995 412
8. R.S. Poston, M. Billingham, and E.G. Hoyt Rapamycin reverses chronic vascular disease in a novel cardiac allograft model Circulation 100 1999 67
9. C.M. Morice, P.W. Serruys, and J.E. Sousa A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 2002 1773
10. M. Pan, J.S. de Lezo, and A. Medina Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: a randomized comparison of a simple versus complex strategy Am Heart J 148 2004 857
11. H. Chen, Q. You, and W. Shen Model establishment of stenosis vein-bridge after coronary artery bypass graft Chin J Comp Med 17 2007 139
12. S.H. Lee, J.E. Lee, and W.Y. Baek Regional delivery of vancomycin using pluronic F-127 to inhibit methicillin resistant Staphylococcus aureus (MRSA) growth in chronic otitis media in vitro and in vivo J Control Release 96 2004 1
13. H.Q. Zhang, A.J. Sun, and K.Q. Wang Scanning electron microscope observation of endothelial cells of different rabbit vascular segments Chin J Anat 25 2003 211
14. P.W. Serruy, E. Rngar, and A.J. Carter Rapamycin eluting stent: the onset of a new era in interventional cardiology Heart 87 2002 305
15. T. Suzuki, G. Kopia, and S. Hayashi Stent based delivery of sirolimus reduced neointimal formation in a porcine coronary model Circulation 104 2001 1188
16. M. Roque, C. Cordon-Cardo, and V. Fuster Modulation of apoptosis, proliferation, and p27 expression in a porcine coronary angioplasty model Atherosclerosis 153 2000 315
17. S.S. Kushwaha, E. Raichlin, and Y. Sheinin Sirolimus affects cardiomyocytes to reduce left ventricular mass in heart transplant recipients European Heart Journal 29 2008 2742